A Trial of Nivolumab, or Nivolumab Plus Ipilimumab, or Nivolumab Plus Platinum-doublet Chemotherapy, Compared to Platinum Doublet Chemotherapy in Patients With Stage IV Non-Small Cell Lung Cancer (NSCLC)
Study Number: 

PH 271415

Phase: 
3
Trial categories: 
Non-Small Cell Lung Cancer (NSCLC)
Lung
Immunotherapy
Antibody therapy
Checkpoint blockade
Principal Investigator: